In another study, A meta-analysis was conducted using publicly available transcriptomic datasets to identify metabolic pathways that might be involved in IBD pathogenesis and found that HCAR3 is upregulated in IBD patients compared to the healthy control, further consolidating the results of our study [57]. Here, HCAR3 is linked to inflammatory bowel disease.